Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.

To strengthen our growing Research & Development team in Heidelberg, Germany, we are looking for a full-time

Project Leader Non-Clinical Development (f/m/d)

(Reference No. R2011)

The successful candidate will be responsible for the non-clinical development of bispecific antibody drug candidates in oncology from lead nomination to IND submission. In this capacity, the Project Leader Non-Clinical Development will head a Non-Clinical Development Team tasked with executing and coordinating all non-clinical development activities and will be an integral member of an international, cross-functional Program Team overseeing development activities and program strategy.

Apply now

Responsibilities

  • Lead non-clinical drug development activities for a bispecific antibody drug candidate in immuno-oncology from lead nomination to IND submission
    • Develop non-clinical program plan in alignment with program strategy
    • Collaborate with pre-clinical scientists and subject matter experts to execute internal and external program-related R&D activities to characterize in vitro and in vivo pharmacology of the drug candidate
    • Work closely with toxicology experts and CMC team to align non-clinical development activities with manufacturing plan and toxicology program
    • Initiate and execute research collaborations with external collaborators and vendors
    • Drive execution according to defined timelines and budget in collaboration with Program Management
  • Represent Non-Clinical Development Team as Non-Clinical Lead in cross-functional Program Team
    • Serve as subject matter expert for target and disease biology
    • Present status of non-clinical development
    • Take a leading role to shape program strategy by providing scientific expertise
    • Support Program Team in preparing program recommendations and presentation to management
    • Support Program Team in budget planning
  • Prepare regulatory documents and support Program Team in interactions with regulatory authorities
  • Prepare study reports and present program status at internal meetings
  • Represent company at international scientific congresses and business meetings, including presentation of program status

Requirements

Professional qualifications, expertise and skills

  • PhD in Life Sciences (Biology, Biochemistry, Medicine, Pharmacy) or MD
  • Demonstrated strong knowledge of immuno-oncology and experience with biologics drug development to IND in a leading role (>3 years)
  • Strong leadership skills and a team-player disposition
  • Excellent oral and written communication skills, capable of influencing a broad spectrum of stakeholders.
  • Full professional proficiency in English

Competencies

  • High intellect, hard-working and ambitious individual with a commitment to make a significant contribution to new therapies.
  • Fully assume responsibility, work proactively and independently
  • Ability to interact within a multi-disciplinary environment with multiple stakeholders
  • Work in a highly structured and organized manner
  • Passionate, inclusive, open-minded, collaborative and forward-thinking approach
  • Analyze, understand and clearly communicate complex scenarios
  • Manage tasks without having direct authority
  • Work under pressure if required, adapt to changes quickly and frequently
  • Possess a results-oriented mindset
  • Be committed to learn, adapt and improve continuously

Opportunity

The successful candidate will have the unique opportunity to take on a leading scientific role in the development of an innovative antibody drug for cancer immunotherapy within a highly motivated, multidisciplinary and collegial team, united in its goal to stop cancer from ever derailing patient’s lives.

For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail: s.hering@affimed.com).

November 2020

Your application

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.